- USA - Pennsylvania - Upper Providence
- Hybrid · 2 days in office
- US$242,250 – US$403,750 pa
- Director · manages people
Accountable for end-to-end clinical development strategy for an antibody-drug conjugate asset across multiple tumour types, from first-in-human through registrational trials and launch. Acts as senior clinical representative at governance forums and leads cross-functional, matrixed teams spanning research, precision medicine, medical affairs and commercial.